Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation

Michael W. Fried, D. Gerard Connaghan, Shoba Sharma, Louis G. Martin, Steven Devine, Kent Holland, Alan Zuckerman, Steven Kaufman, John Wingard, Thomas D Boyer

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Hepatic venoocclusive disease (VOD) is a common, life-threatening complication of bone marrow transplantation (BMT). Portal hypertension is usually present and accounts for many of the clinical manifestations of this syndrome. We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for the management of VOD after BMT. TIPS was performed in six patients with histologically confirmed VOD who had progressive jaundice and ascites. Portal hypertension was improved by TIPS in all patients (mean portal pressure gradient before TIPS, 20.2 ± 4.6 vs. 6.7 ± 1.9 mm Hg post- TIPS, P < .004). Three patients who underwent TIPS late in the course of VOD did not demonstrate any clinical improvement after TIPS and expired within 2 weeks of the procedure. The remaining three patients had less advanced disease and demonstrated decreases in serum bilirubin, improvement in coagulopathy, and decreased ascites after TIPS. Two patients subsequently expired, one with persistent histological changes of VOD. The lone survivor continues to do well with resolution of ascites, jaundice, and coagulopathy as of her last outpatient visit. TIPS was an effective method for portal decompression in patients with VOD after BMT, and was associated with clinical improvement in some patients. However, these effects may be transient and may not improve overall survival.

Original languageEnglish (US)
Pages (from-to)588-591
Number of pages4
JournalHepatology
Volume24
Issue number3
DOIs
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Bone Marrow Transplantation
Ascites
Portal Hypertension
Jaundice
Portal Pressure
Disease Management
Decompression
Bilirubin
Survivors
Outpatients

ASJC Scopus subject areas

  • Hepatology

Cite this

Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. / Fried, Michael W.; Connaghan, D. Gerard; Sharma, Shoba; Martin, Louis G.; Devine, Steven; Holland, Kent; Zuckerman, Alan; Kaufman, Steven; Wingard, John; Boyer, Thomas D.

In: Hepatology, Vol. 24, No. 3, 09.1996, p. 588-591.

Research output: Contribution to journalArticle

Fried, MW, Connaghan, DG, Sharma, S, Martin, LG, Devine, S, Holland, K, Zuckerman, A, Kaufman, S, Wingard, J & Boyer, TD 1996, 'Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation', Hepatology, vol. 24, no. 3, pp. 588-591. https://doi.org/10.1053/jhep.1996.v24.pm0008781329
Fried, Michael W. ; Connaghan, D. Gerard ; Sharma, Shoba ; Martin, Louis G. ; Devine, Steven ; Holland, Kent ; Zuckerman, Alan ; Kaufman, Steven ; Wingard, John ; Boyer, Thomas D. / Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. In: Hepatology. 1996 ; Vol. 24, No. 3. pp. 588-591.
@article{23df7d1c77d14c30ba77c853da7b1579,
title = "Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation",
abstract = "Hepatic venoocclusive disease (VOD) is a common, life-threatening complication of bone marrow transplantation (BMT). Portal hypertension is usually present and accounts for many of the clinical manifestations of this syndrome. We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for the management of VOD after BMT. TIPS was performed in six patients with histologically confirmed VOD who had progressive jaundice and ascites. Portal hypertension was improved by TIPS in all patients (mean portal pressure gradient before TIPS, 20.2 ± 4.6 vs. 6.7 ± 1.9 mm Hg post- TIPS, P < .004). Three patients who underwent TIPS late in the course of VOD did not demonstrate any clinical improvement after TIPS and expired within 2 weeks of the procedure. The remaining three patients had less advanced disease and demonstrated decreases in serum bilirubin, improvement in coagulopathy, and decreased ascites after TIPS. Two patients subsequently expired, one with persistent histological changes of VOD. The lone survivor continues to do well with resolution of ascites, jaundice, and coagulopathy as of her last outpatient visit. TIPS was an effective method for portal decompression in patients with VOD after BMT, and was associated with clinical improvement in some patients. However, these effects may be transient and may not improve overall survival.",
author = "Fried, {Michael W.} and Connaghan, {D. Gerard} and Shoba Sharma and Martin, {Louis G.} and Steven Devine and Kent Holland and Alan Zuckerman and Steven Kaufman and John Wingard and Boyer, {Thomas D}",
year = "1996",
month = "9",
doi = "10.1053/jhep.1996.v24.pm0008781329",
language = "English (US)",
volume = "24",
pages = "588--591",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation

AU - Fried, Michael W.

AU - Connaghan, D. Gerard

AU - Sharma, Shoba

AU - Martin, Louis G.

AU - Devine, Steven

AU - Holland, Kent

AU - Zuckerman, Alan

AU - Kaufman, Steven

AU - Wingard, John

AU - Boyer, Thomas D

PY - 1996/9

Y1 - 1996/9

N2 - Hepatic venoocclusive disease (VOD) is a common, life-threatening complication of bone marrow transplantation (BMT). Portal hypertension is usually present and accounts for many of the clinical manifestations of this syndrome. We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for the management of VOD after BMT. TIPS was performed in six patients with histologically confirmed VOD who had progressive jaundice and ascites. Portal hypertension was improved by TIPS in all patients (mean portal pressure gradient before TIPS, 20.2 ± 4.6 vs. 6.7 ± 1.9 mm Hg post- TIPS, P < .004). Three patients who underwent TIPS late in the course of VOD did not demonstrate any clinical improvement after TIPS and expired within 2 weeks of the procedure. The remaining three patients had less advanced disease and demonstrated decreases in serum bilirubin, improvement in coagulopathy, and decreased ascites after TIPS. Two patients subsequently expired, one with persistent histological changes of VOD. The lone survivor continues to do well with resolution of ascites, jaundice, and coagulopathy as of her last outpatient visit. TIPS was an effective method for portal decompression in patients with VOD after BMT, and was associated with clinical improvement in some patients. However, these effects may be transient and may not improve overall survival.

AB - Hepatic venoocclusive disease (VOD) is a common, life-threatening complication of bone marrow transplantation (BMT). Portal hypertension is usually present and accounts for many of the clinical manifestations of this syndrome. We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for the management of VOD after BMT. TIPS was performed in six patients with histologically confirmed VOD who had progressive jaundice and ascites. Portal hypertension was improved by TIPS in all patients (mean portal pressure gradient before TIPS, 20.2 ± 4.6 vs. 6.7 ± 1.9 mm Hg post- TIPS, P < .004). Three patients who underwent TIPS late in the course of VOD did not demonstrate any clinical improvement after TIPS and expired within 2 weeks of the procedure. The remaining three patients had less advanced disease and demonstrated decreases in serum bilirubin, improvement in coagulopathy, and decreased ascites after TIPS. Two patients subsequently expired, one with persistent histological changes of VOD. The lone survivor continues to do well with resolution of ascites, jaundice, and coagulopathy as of her last outpatient visit. TIPS was an effective method for portal decompression in patients with VOD after BMT, and was associated with clinical improvement in some patients. However, these effects may be transient and may not improve overall survival.

UR - http://www.scopus.com/inward/record.url?scp=16044374637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16044374637&partnerID=8YFLogxK

U2 - 10.1053/jhep.1996.v24.pm0008781329

DO - 10.1053/jhep.1996.v24.pm0008781329

M3 - Article

VL - 24

SP - 588

EP - 591

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -